Please login to the form below

Not currently logged in
Email:
Password:

UK launch of RebiDose for treatment of MS

Merck Serono has launched the UK's first pre-filled, single-use disposable pen for the self-administration of Rebif

Merck's division for innovative prescription pharmaceuticals, Merck Serono, has launched the UK's first pre-filled, single-use disposable pen for the self-administration of Rebif, a disease-modifying drug for the treatment of relapsing forms of multiple sclerosis (MS).

The RebiDose device is a pre-filled, pre-loaded, single-use disposable pen and is the first and only injection delivery device that needs no assembly or priming by the patient.

According to MS nurse specialist at Herefordshire PCT, Del Thomas: "The simplicity of the RebiDose pen may be ideal for those patients with MS who have significant cognitive, visual or dexterity impairment. The needle is hidden and the rubber grips can maximise control by the patient throughout the entire injection process."

RebiDose pens are available in strengths of 22mcg and 44mcg as well as the titration pack for initiation of treatment. Each pen can be stored in the fridge for up to 18 months, and at room temperature of up to 25 degrees for a single period of 14 days, giving patients flexibility with storage conditions when travelling. 

RebiDose has been approved in the EU. While the UK was the first to launch RebiDose, other European countries are expected to follow shortly.

3rd November 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics